Encouraging anti-tumour activity seen across all dose levels and in various tumour indications Clinical benefit rate of 80% for 10 patients with HER2+ oesophageal cancer who had received prior therapy ...

KFF Health News' editor-at-large for public health recently took to the airwaves to discuss topical stories. Here’s a ...